DAMAE Medical Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
2ndary - Private
- Investors
-
15
DAMAE Medical General Information
Description
Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's platform is based on proprietary technology that offers cellular-resolution imaging of the skin similar to histology without the need for tissue excision and processing, helping healthcare professionals in immediate and non-invasive diagnosis of skin cancers and helping dermatologists to have a deep look at the skin.
Contact Information
Website
www.damae-medical.comCorporate Office
- 14 rue Sthrau
- 75013 Paris
- France
Corporate Office
- 14 rue Sthrau
- 75013 Paris
- France
DAMAE Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series A) | 03-Feb-2022 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 10-Sep-2020 | Completed | Generating Revenue | |||
| 9. Grant | 01-Sep-2019 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 13-Mar-2018 | Completed | Generating Revenue | |||
| 7. Seed Round | 19-Apr-2017 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 13-Oct-2015 | Completed | Startup | |||
| 5. Grant | 05-Jul-2015 | Completed | Startup | |||
| 4. Accelerator/Incubator | 05-Jun-2015 | $109K | Completed | Startup | ||
| 3. Accelerator/Incubator | 24-Mar-2015 | $109K | $109K | Completed | Startup |
DAMAE Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary | ||||||||
| P Shares | 100,000 | $0.113144 | $22.63 | $22.63 | 1x | $22.63 | 22.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
DAMAE Medical Comparisons
Industry
Financing
Details
DAMAE Medical Competitors (3)
One of DAMAE Medical’s 3 competitors is VivoSight, a Venture Capital-Backed company based in Maidstone, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| VivoSight | Venture Capital-Backed | Maidstone, United Kingdom | ||||
| SciBase | Formerly PE-Backed | Stockholm, Sweden | ||||
| Skin Analytics | Venture Capital-Backed | Cambridge, United Kingdom |
DAMAE Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
DAMAE Medical Patents
DAMAE Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3128627-A1 | Systems and methods for characterizing a region of interest of a biological tissue | Active | 29-Oct-2021 | ||
| AU-2022377223-A1 | Systems for characterizing a region of interest of a biological tissue | Active | 29-Oct-2021 | ||
| EP-4423754-A1 | Systems for characterizing a region of interest of a biological tissue | Pending | 29-Oct-2021 | ||
| US-20240420323-A1 | Systems for characterizing a region of interest of a biological tissue | Active | 29-Oct-2021 | ||
| AU-2022377223-B2 | Systems for characterizing a region of interest of a biological tissue | Active | 29-Oct-2021 | G06T7/0012 |
DAMAE Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DAMAE Medical Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNP Paribas Développement | PE/Buyout | Minority | ||
| European Innovation Council | Venture Capital | Minority | ||
| Prevent2Care Lab | Accelerator/Incubator | |||
| Kurma Partners | Venture Capital | Minority | ||
| News Invest | Corporation | Minority |
DAMAE Medical FAQs
-
When was DAMAE Medical founded?
DAMAE Medical was founded in 2014.
-
Where is DAMAE Medical headquartered?
DAMAE Medical is headquartered in Paris, France.
-
What is the size of DAMAE Medical?
DAMAE Medical has 34 total employees.
-
What industry is DAMAE Medical in?
DAMAE Medical’s primary industry is Diagnostic Equipment.
-
Is DAMAE Medical a private or public company?
DAMAE Medical is a Private company.
-
What is DAMAE Medical’s current revenue?
The current revenue for DAMAE Medical is .
-
How much funding has DAMAE Medical raised over time?
DAMAE Medical has raised $8.07M.
-
Who are DAMAE Medical’s investors?
BNP Paribas Développement, European Innovation Council, Prevent2Care Lab, Kurma Partners, and News Invest are 5 of 15 investors who have invested in DAMAE Medical.
-
Who are DAMAE Medical’s competitors?
VivoSight, SciBase, and Skin Analytics are competitors of DAMAE Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
